#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infective uveitis Ataxia telangiectasia Metachromatic leukodystrophy CDKL5 deficiency disorder Angelman's syndrome Breast angiosarcoma Nasopharyngeal cancer Medulloblastoma Interstitial lung disease Neovascular age-related macular degeneration Cutaneous T-cell lymphoma stage II Paroxysmal nocturnal haemoglobinuria Myelodysplastic syndrome with excess blasts Medulloblastoma recurrent Cholangiosarcoma More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy – Basic Information Rosai-Dorfman syndrome – Treatment Hepatic angiosarcoma – Treatment Bronchiolitis obliterans syndrome – Life with Disease Glycogen storage disease type V – Trials in Disease Angiosarcoma – Life with Disease Usher’s syndrome – Basic Information Hereditary ataxia – Life with Disease Antisynthetase syndrome – Diagnostics Acute respiratory distress syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Hypochlorite Domperidone A/H1N1 INFLUENZA VACCINE Aldesleukin Temozolomide Anhydrous Cyclophosphamide Quavonlimab Insulin Lispro Cinchocaine Hydrochloride Orismilast Etelcalcetide Lt3001 SUMATRIPTAN Vortioxetine Hydrobromide Tamoxifen Citrate RO7837195 Immunoglobulin M Mrna-3210 Voriconazole Sodium Phenylbutyrate More therapies…

    Learn about Your Condition

    Testis cancer Corneal graft rejection Inner ear disorder Tourette's disorder Genital infection female Fragile X syndrome Meningioma Epithelioid sarcoma Eye pain Chronic coronary syndrome Castleman's disease Joint stabilisation Infection Polymyositis HIV infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Fibrinogen Concentrate (FGTW) for Managing Bleeding in Patients Undergoing Complex Cardiac Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    Investigated Drugs:
    • Human Fibrinogen
    Czechia Germany Italy Spain Sweden

  • Infusion Study of ARI-0001 Cells for Patients with Resistant or Refractory CD19+ Acute Lymphoid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Dexchlorpheniramine
    • Varnimcabtagene Autoleucel
    • Bendamustine
    Spain

  • Study on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Nipocalimab
    • Human Normal Immunoglobulin
    Czechia France Germany Greece Italy Poland +2

  • Study on Preventing Heart Problems in Patients with Diffuse Large B-Cell Lymphoma Using Dexrazoxane and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Dexrazoxane
    • Pegfilgrastim
    • Doxorubicin Hydrochloride
    The Netherlands

  • Study of KYV-101 Therapy for Patients with Refractory Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Kyv-101
    • ZILUCOPLAN
    • Eculizumab
    Germany

  • Study Comparing MK-2870 and Pembrolizumab with Chemotherapy for Patients with Advanced Hormone Receptor Positive Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Doxorubicin Hydrochloride, Liposomal
    • Capecitabine
    • Dexamethasone Acetate
    Belgium Czechia Denmark France Germany Greece +10
Previous Page
1 … 481 482 483 484 485 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!